{"id":1235,"date":"2023-08-10T15:23:43","date_gmt":"2023-08-10T15:23:43","guid":{"rendered":"https:\/\/pediatricbrainfoundation.org\/archive\/super-refractory-status-epilepticus\/"},"modified":"2023-08-10T15:23:43","modified_gmt":"2023-08-10T15:23:43","slug":"super-refractory-status-epilepticus","status":"publish","type":"page","link":"https:\/\/pediatricbrainfoundation.org\/archive\/super-refractory-status-epilepticus\/","title":{"rendered":"Super-refractory status epilepticus"},"content":{"rendered":"<div class=\"row-fluid\">\n<section class=\"content-top span12\">\n      <a id=\"main-content\"><\/a><\/p>\n<h1 class=\"page-header\">super-refractory status epilepticus<\/h1>\n<\/section><\/div>\n<div class=\"row-fluid\">\n<section class=\"main-content span12\">\n<section id=\"block-system-main\" class=\"block-system block-page-content clearfix\">\n<div class=\"section-in\">\n<div class=\"section-inn\">\n<div class=\"section-innn\">\n<div class=\"term-listing-heading\">\n<div id=\"taxonomy-term-3252\" class=\"taxonomy-term vocabulary-tags\">\n<div class=\"content\">\n      <\/div>\n<\/div>\n<\/div>\n<article id=\"node-6364\" class=\"node node-science-article node-teaser clearfix\">\n<h2 class=\"node-title clearfix\"><a href=\"https:\/\/pediatricbrainfoundation.org\/archive\/educate\/science-news\/uc-davis-investigational-medication-used-resolve-life-threatening-seizures\/\">UC Davis investigational medication used to resolve life-threatening seizures in children<\/a><\/h2>\n<div class=\"submitted\">\n            <span class=\"created\">Wednesday, November 12, 2014<\/span>&nbsp;&nbsp;\u00b7&nbsp;&nbsp;Posted by <a href=\"http:\/\/www.ucdmc.ucdavis.edu\/publish\/news\/newsroom\/9456\" target=\"_blank\" rel=\"noopener\">University of California, Davis<\/a>    <\/div>\n<p>  <!--\nTHIS FILE IS NOT USED AND IS HERE AS A STARTING POINT FOR CUSTOMIZATION ONLY.\nSee http:\/\/api.drupal.org\/api\/function\/theme_field\/7 for details.\nAfter copying this file to your theme's folder and customizing it, remove this\nHTML comment.\n--><\/p>\n<div id=\"body\" class=\"field field-name-body field-type-text-with-summary field-label-hidden prose\">\n<div class=\"field-items\">\n<div class=\"field-item even\">\n<p class=\"tkgyxz44ddvou8s4e\">The investigational formulation of\u00a0allopregnanolone was manufactured by UC Davis Health System&#8217;s Good Manufacturing Practice Laboratory. Two children were treated with the allopregnanolone formulation, one at UC Davis Children\u2019s Hospital, the other at the Ann &#038; Robert Lurie Children\u2019s Hospital in Chicago. Both children were weaned from general anesthetics and other seizure treatments and their seizures resolved. In both instances the children are recovering.<\/p>\n<\/div><\/div>\n<\/div>\n<\/article>\n<p> <!-- \/.node -->\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p> <!-- \/.block --><br \/>\n      <\/section>\n<\/p><\/div>\n","protected":false,"raw":""},"excerpt":{"rendered":"<p>super-refractory status epilepticus UC Davis investigational medication used to [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template_2.php","meta":{"footnotes":""},"class_list":["post-1235","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>super-refractory status epilepticus | Pediatric Brain Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pediatricbrainfoundation.org\/archive\/super-refractory-status-epilepticus\/\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"super-refractory status epilepticus | Pediatric Brain Foundation\" \/>\n<meta property=\"og:description\" content=\"super-refractory status epilepticus UC Davis investigational medication used to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pediatricbrainfoundation.org\/archive\/super-refractory-status-epilepticus\/\" \/>\n<meta property=\"og:site_name\" content=\"Neurological Disorders\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"super-refractory status epilepticus | Pediatric Brain Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pediatricbrainfoundation.org\/archive\/super-refractory-status-epilepticus\/","og_type":"article","og_title":"super-refractory status epilepticus | Pediatric Brain Foundation","og_description":"super-refractory status epilepticus UC Davis investigational medication used to [&hellip;]","og_url":"https:\/\/pediatricbrainfoundation.org\/archive\/super-refractory-status-epilepticus\/","og_site_name":"Neurological Disorders","twitter_card":"summary_large_image"},"_links":{"self":[{"href":"https:\/\/pediatricbrainfoundation.org\/archive\/wp-json\/wp\/v2\/pages\/1235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pediatricbrainfoundation.org\/archive\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pediatricbrainfoundation.org\/archive\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/pediatricbrainfoundation.org\/archive\/wp-json\/wp\/v2\/comments?post=1235"}],"version-history":[{"count":0,"href":"https:\/\/pediatricbrainfoundation.org\/archive\/wp-json\/wp\/v2\/pages\/1235\/revisions"}],"wp:attachment":[{"href":"https:\/\/pediatricbrainfoundation.org\/archive\/wp-json\/wp\/v2\/media?parent=1235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}